Procter & Gamble Health Limited (BOM:500126)
India · Delayed Price · Currency is INR 5,657.90
-104.30 (-1.81%)
At close: Sep 4, 2026
Procter & Gamble Health Market Cap
Procter & Gamble Health has a market cap or net worth of 93.92 billion as of September 4, 2026. Its market cap has decreased by -10.50% in one year.
Market Cap
93.92B
Enterprise Value
92.16B
Revenue
14.33B
Ranking
n/a
PE Ratio
29.79
Stock Price
5,657.90
ChartMarket Cap Chart
Since June 14, 1999, Procter & Gamble Health's market cap has increased from 9.75B to 93.92B, an increase of 863.67%. That is a compound annual growth rate of 8.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 93.92B | -0.76% |
| Dec 31, 2025 | 94.63B | 8.85% |
| Dec 31, 2024 | 86.94B | 5.90% |
| Dec 29, 2023 | 82.10B | 23.12% |
| Dec 30, 2022 | 66.69B | -24.14% |
| Dec 31, 2021 | 87.91B | -22.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Caplin Point Laboratories | 213.61B |
| Granules India | 210.03B |
| AstraZeneca Pharma India | 173.27B |
| Jubilant Pharmova | 146.31B |
| Viyash Scientific | 115.84B |
| Sanofi India | 72.55B |
| Bliss GVS Pharma | 71.07B |
| Morepen Laboratories | 62.30B |